FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

48 results

aphexda
(Motixafortide)
BioLineRx USA Inc
Usage: APHEXDA is indicated, in combination with filgrastim (G-CSF), for mobilizing hematopoietic stem cells into peripheral blood for collection and autologous transplantation in patients with multiple myeloma.
bortezomib
(Bortezomib)
Ingenus Pharmaceuticals, LLC
Usage: Bortezomib for Injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.
bortezomib
(Bortezomib)
Novadoz Pharmaceuticals LLC
Usage: Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.
bortezomib
(BORTEZOMIB)
Hospira, Inc.
Usage: Bortezomib for Injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.
bortezomib
(bortezomib)
Hikma Pharmaceuticals USA Inc.
Usage: Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.
bortezomib
(Bortezomib)
NorthStar RxLLC
Usage: Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.
boruzu
(Bortezomib)
Amneal Pharmaceuticals LLC
Usage: BORUZU is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.
carmustine
(carmustine)
Zydus Pharmaceuticals USA Inc.
Usage: Carmustine for injection is indicated for palliative therapy in brain tumors (glioblastoma, brainstem glioma, medulloblastoma, astrocytoma, ependymoma, metastatic brain tumors), multiple myeloma (with prednisone), and relapsed or refractory Hodgkin's and Non-Hodgkin's lymphomas (in combination with other approved drugs).
carmustine
(CARMUSTINE)
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Usage: Carmustine for Injection, USP is indicated for palliative therapy as a single agent or in combination therapy for brain tumors (e.g., glioblastoma), multiple myeloma (with prednisone), and relapsed or refractory Hodgkin's and Non-Hodgkin's lymphomas (with other approved drugs).
carmustine
(CARMUSTINE)
Sandoz Inc.
Usage: Carmustine for injection is indicated for palliative therapy as a single agent or in combination for brain tumors, multiple myeloma (with prednisone), and relapsed or refractory Hodgkin's and Non-Hodgkin's lymphomas (with other approved drugs).

Medications for Multiple Myeloma

aphexda

bortezomib

bortezomib

bortezomib

bortezomib

bortezomib

boruzu

carmustine

carmustine

carmustine